帝人株式会社 2026年3月期通期業績予想の修正に関するお知らせ

This document announces that Teijin Limited has revised its consolidated earnings forecast for the fiscal year ending March 2026. The revision is influenced by the delay in the completion of the stock transfer of DuPont Teijin Advanced Papers and the company's strategic focus on improving profitability in its pharmaceutical business. As a result, operating profit and net income attributable to the parent company are expected to be revised downward. However, the dividend forecast remains unchanged at 50 yen per share.